Chiral separation of the four stereoisomers of a novel antianginal agent using a dual cyclodextrin system in capillary electrophoresis.

Abstract : Reported here is an analytical method enabling the stereochemical resolution of a new antianginal compound possessing two stereogenic centers, leading to four stereoisomers. Only one of these isomers is currently under development as a novel antianginal agent and consequently, the other three isomers are considered as unwanted chiral impurities. Therefore, an enantioselective method is required in order to check its enantiomeric purity. This paper presents a method exploiting the high efficiency of capillary electrophoresis and the complexing properties of cyclodextrins to achieve the separation of the four stereoisomers of this weakly basic compound (pKa = 7.4). For this purpose, the combination of a neutral cyclodextrin, hydroxypropyl-gamma-cyclodextrin (HP-gamma-CD), and an anionic cyclodextrin, carboxymethyl-beta-cyclodextrin (CM-beta-CD), was added to the separation buffer running in an uncoated silica capillary. After selection of the suitable cyclodextrin system, satisfactorily separation conditions were as follows: 30 mM phosphate buffer (pH 6.4) containing 10 mM of HP-gamma-CD and 10 mM of CM-beta-CD, running voltage +30 kV. The resulting run time and resolutions were respectively about 17 min and between 1.95 and 2.84. Linearity curves (0.993 < r2 < 0.998) are also shown.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02087618
Contributor : Laëtitia Legoupil <>
Submitted on : Tuesday, April 2, 2019 - 11:34:24 AM
Last modification on : Thursday, June 6, 2019 - 12:52:01 PM

Links full text

Identifiers

Collections

Citation

Martine Beaufour, Philippe Morin, Jean-Paul Ribet. Chiral separation of the four stereoisomers of a novel antianginal agent using a dual cyclodextrin system in capillary electrophoresis.. Journal of Separation Science, Wiley-VCH Verlag, 2005, 28 (6), pp.529-33. ⟨10.1002/jssc.200400097⟩. ⟨hal-02087618⟩

Share

Metrics

Record views

13